51
IRUS TotalDownloads
Altmetric
Financial modelling of femtosecond laser-assisted cataract surgery within the National Health Service using a 'hub and spoke' model for the delivery of high-volume cataract surgery
File | Description | Size | Format | |
---|---|---|---|---|
Financial modelling of laser suergery_BMJ openl.pdf | Published version | 952.8 kB | Adobe PDF | View/Open |
Title: | Financial modelling of femtosecond laser-assisted cataract surgery within the National Health Service using a 'hub and spoke' model for the delivery of high-volume cataract surgery |
Authors: | Roberts, HW Ni, MZ O'Brart, DPS |
Item Type: | Journal Article |
Abstract: | Aims To develop financial models which offset additional costs associated with femtosecond laser (FL)-assisted cataract surgery (FLACS) against improvements in productivity and to determine important factors relating to its implementation into the National Health Service (NHS). Methods FL platforms are expensive, in initial purchase and running costs. The additional costs associated with FL technology might be offset by an increase in surgical efficiency. Using a ‘hub and spoke’ model to provide high-volume cataract surgery, we designed a financial model, comparing FLACS against conventional phacoemulsification surgery (CPS). The model was populated with averaged financial data from 4 NHS foundation trusts and 4 commercial organisations manufacturing FL platforms. We tested our model with sensitivity and threshold analyses to allow for variations or uncertainties. Results The averaged weekly workload for cataract surgery using our hub and spoke model required either 8 or 5.4 theatre sessions with CPS or FLACS, respectively. Despite reduced theatre utilisation, CPS (average £433/case) was still found to be 8.7% cheaper than FLACS (average £502/case). The greatest associated cost of FLACS was the patient interface (PI) (average £135/case). Sensitivity analyses demonstrated that FLACS could be less expensive than CPS, but only if increased efficiency, in terms of cataract procedures per theatre list, increased by over 100%, or if the cost of the PI was reduced by almost 70%. Conclusions The financial viability of FLACS within the NHS is currently precluded by the cost of the PI and the lack of knowledge regarding any gains in operational efficiency. |
Issue Date: | 1-Mar-2017 |
Date of Acceptance: | 23-Dec-2016 |
URI: | http://hdl.handle.net/10044/1/53436 |
DOI: | https://dx.doi.org/10.1136/bmjopen-2016-013616 |
ISSN: | 2044-6055 |
Publisher: | BMJ Journals |
Journal / Book Title: | BMJ Open |
Volume: | 7 |
Issue: | 3 |
Copyright Statement: | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Sponsor/Funder: | Guys & St Thomas NHS Foundation Trust |
Funder's Grant Number: | WSSS_P64463 |
Keywords: | Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine COST-EFFECTIVENESS PHACOEMULSIFICATION SAFETY OUTCOMES |
Publication Status: | Published |
Article Number: | e013616 |
Appears in Collections: | Department of Surgery and Cancer |